Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Karas

Showing results (151-160 of 152) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 152 results.
Biochemical Pharmacology|September 28, 2016
Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazolesSimon B M Kretschmer, Stefano Woltersdorf, Dominik Vogt, et al.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Pageof 16

Showing results (151-160 of 152) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 152 results.
Biochemical Pharmacology|September 28, 2016
Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazolesSimon B M Kretschmer, Stefano Woltersdorf, Dominik Vogt, et al.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Pageof 16